Stock PHAR.N0000 COLOMBO CITY HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Colombo City Holdings PLC

Equities

PHAR.N0000

LK0051N00009

Drug Retailers

End-of-day quote Colombo S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
50.7 LKR 0.00% Intraday chart for Colombo City Holdings PLC +1.20% -1.93%
04-19 Colombo City Holdings PLC Announces Board Subcommittees Changes CI
02-15 Colombo City Holdings PLC Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 973.6 901.1 1,021 1,084 1,235 1,280
Enterprise Value (EV) 1 957.7 1,069 1,013 1,220 1,075 986.5
P/E ratio 3.71 x 3.68 x 5.54 x -3.55 x 37.9 x 14.9 x
Yield 1.96% 4.24% - 5.87% - -
Capitalization / Revenue 8.48 x 54.4 x 16.7 x 19.4 x 32.1 x 14.5 x
EV / Revenue 8.34 x 64.6 x 16.6 x 21.8 x 27.9 x 11.2 x
EV / EBITDA 68.1 x -123 x 38.8 x 85.3 x -294 x 24 x
EV / FCF 1.52 x -17.7 x 6.4 x -1.76 x 4.29 x 21.7 x
FCF Yield 65.8% -5.64% 15.6% -56.8% 23.3% 4.6%
Price to Book 0.52 x 0.43 x 0.45 x 0.57 x 0.64 x 0.63 x
Nbr of stocks (in thousands) 25,457 25,457 25,457 25,457 25,457 25,457
Reference price 2 38.24 35.40 40.11 42.59 48.50 50.30
Announcement Date 31/08/18 03/09/19 05/11/20 31/08/21 31/08/22 28/08/23
1LKR in Million2LKR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 114.9 16.55 61.05 56.02 38.47 88.21
EBITDA 1 14.07 -8.701 26.12 14.31 -3.652 41.16
EBIT 1 14.01 -8.825 25.42 13.57 -4.806 40.42
Operating Margin 12.19% -53.32% 41.64% 24.21% -12.49% 45.82%
Earnings before Tax (EBT) 1 287 222.1 230.3 -309 57.43 222.2
Net income 1 262.4 244.6 184.9 -305.7 32.61 86.08
Net margin 228.39% 1,478.18% 302.82% -545.64% 84.79% 97.59%
EPS 2 10.31 9.610 7.245 -12.01 1.281 3.373
Free Cash Flow 1 630.5 -60.23 158.4 -693.1 250.8 45.39
FCF margin 548.83% -363.95% 259.48% -1,237.17% 652.06% 51.46%
FCF Conversion (EBITDA) 4,482.29% - 606.55% - - 110.28%
FCF Conversion (Net income) 240.31% - 85.69% - 769.06% 52.73%
Dividend per Share 2 0.7500 1.500 - 2.500 - -
Announcement Date 31/08/18 03/09/19 05/11/20 31/08/21 31/08/22 28/08/23
1LKR in Million2LKR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 168 - 136 - -
Net Cash position 1 15.9 - 7.77 - 160 294
Leverage (Debt/EBITDA) - -19.25 x - 9.53 x - -
Free Cash Flow 1 630 -60.2 158 -693 251 45.4
ROE (net income / shareholders' equity) 14.9% 12.3% 8.48% -14.6% 1.7% 4.35%
ROA (Net income/ Total Assets) 0.49% -0.26% 0.67% 0.38% -0.15% 1.16%
Assets 1 53,885 -95,414 27,528 -80,360 -22,385 7,390
Book Value Per Share 2 73.90 82.00 89.30 74.70 76.00 79.40
Cash Flow per Share 2 0.6300 1.540 0.4300 0.8100 1.370 0.3700
Capex 1 0.09 0.01 0.81 1.12 0.06 0.12
Capex / Sales 0.08% 0.08% 1.32% 1.99% 0.15% 0.14%
Announcement Date 31/08/18 03/09/19 05/11/20 31/08/21 31/08/22 28/08/23
1LKR in Million2LKR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Drug Retailers

1st Jan change Capi.
COLOMBO CITY HOLDINGS PLC Stock Colombo City Holdings PLC
-1.93% 4.29M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-29.72% 15.82B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-22.89% 12.65B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-23.58% 6.6B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+12.34% 6.3B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-6.01% 6.11B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-1.17% 4.69B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+64.02% 4.75B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.50% 4.02B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-8.59% 3.59B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. PHAR.N0000 Stock
  4. Financials Colombo City Holdings PLC